APA

Sheng G., Chen S., Dong C., Zhang R., Miao M., Wu D., Tan S. C., Liu C. & Xiong T. (20171011). Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis. : Journal of medical economics.

Chicago

Sheng Guangying, Chen Suning, Dong Chaohui, Zhang Ri, Miao Miao, Wu Depei, Tan Seng Chuen, Liu Chao and Xiong Tengbin. 20171011. Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis. : Journal of medical economics.

Harvard

Sheng G., Chen S., Dong C., Zhang R., Miao M., Wu D., Tan S. C., Liu C. and Xiong T. (20171011). Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis. : Journal of medical economics.

MLA

Sheng Guangying, Chen Suning, Dong Chaohui, Zhang Ri, Miao Miao, Wu Depei, Tan Seng Chuen, Liu Chao and Xiong Tengbin. Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis. : Journal of medical economics. 20171011.